Dianthus Therapeutics (DNTH) Q1 2022 Earnings Report

445 Followers

DNTH Q1 2022 EPS Results

Actual EPS: -$6.24
Consensus EPS: -$5.09
Beat/Miss: Missed by -$1.15
One Year Ago EPS: -$5.76

DNTH Q1 2022 Revenue Results

Actual Revenue: $0
Expected Revenue: $0
Beat/Miss: Met expectations
YoY Revenue Growth: ―

Earnings Announcement Details

Quarter: Q1 2022
Date: 05/16/2022
Time: Before Open
Conference Call: Monday, May 16, 2022

DNTH Upcoming Earnings

Dianthus Therapeutics's next earnings date is estimated for March 16, 2027, based on past reporting schedules.

Q1 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DNTH Earnings History

DNTH earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Mar 16, 2027	2026 (Q4)	-0.96-	-1.43	―	―
Nov 04, 2026	2026 (Q3)	-0.94-0.81	-0.97	16.49% (+0.16)
Aug 04, 2026	2026 (Q2)	-0.85-0.90	-0.88	-2.27% (-0.02)
May 05, 2026	2026 (Q1)	-1.07-0.85	-0.82	-3.66% (-0.03)
Mar 09, 2026	2025 (Q4)	-1.01-1.43	-0.81	-76.54% (-0.62)
Nov 05, 2025	2025 (Q3)	-0.87-0.97	-0.74	-31.08% (-0.23)
Aug 07, 2025	2025 (Q2)	-0.87-0.88	-0.51	-72.55% (-0.37)
May 12, 2025	2025 (Q1)	-0.85-0.82	-0.54	-51.85% (-0.28)
Mar 11, 2025	2024 (Q4)	-0.85-0.81	-0.71	-14.08% (-0.10)
Nov 07, 2024	2024 (Q3)	-0.59-0.74	-3.78	80.42% (+3.04)
Aug 08, 2024	2024 (Q2)	-0.55-0.51	-3.12	83.65% (+2.61)
May 09, 2024	2024 (Q1)	-0.44-0.54	-7.52	92.82% (+6.98)
Mar 21, 2024	2023 (Q4)	-0.94-0.71	-4.8	85.21% (+4.09)
Nov 09, 2023	2023 (Q3)	-0.56-3.78	-4.32	12.50% (+0.54)
Sep 18, 2023	2023 (Q2)	-0.80-0.87	-4.64	81.34% (+3.77)
May 11, 2023	2023 (Q1)	-0.40-0.47	-0.39	-20.51% (-0.08)
Mar 07, 2023	2022 (Q4)	-0.26-0.30	-0.33	9.09% (+0.03)
Nov 03, 2022	2022 (Q3)	-4.64-4.32	-4.8	10.00% (+0.48)
Aug 04, 2022	2022 (Q2)	-5.44-4.64	-5.12	9.38% (+0.48)
May 16, 2022	2022 (Q1)	-5.09-6.24	-5.76	-8.33% (-0.48)
Mar 08, 2022	2021 (Q4)	-5.02-5.28	-6.08	13.16% (+0.80)
Nov 04, 2021	2021 (Q3)	-5.26-4.80	-5.92	18.92% (+1.12)
Aug 05, 2021	2021 (Q2)	-5.96-5.12	-7.68	33.33% (+2.56)
May 06, 2021	2021 (Q1)	-6.21-5.76	-8.16	29.41% (+2.40)
Mar 03, 2021	2020 (Q4)	-6.21-6.08	-9.44	35.59% (+3.36)
Nov 05, 2020	2020 (Q3)	-6.88-5.92	-8.64	31.48% (+2.72)
Aug 06, 2020	2020 (Q2)	-8.60-7.68	-7.68	0.00% (+0.00)
May 07, 2020	2020 (Q1)	-9.44-8.16	-7.04	-15.91% (-1.12)
Mar 03, 2020	2019 (Q4)	-9.28-9.44	-8	-18.00% (-1.44)
Nov 13, 2019	2019 (Q3)	-8.42-8.64	-7.84	-10.20% (-0.80)
Aug 08, 2019	2019 (Q2)	―-0.48	-3.13	84.66% (+2.65)
May 09, 2019	2019 (Q1)	―-0.44	-4.45	90.12% (+4.01)
Mar 19, 2019	2018 (Q4)	―-0.50	―	―
Nov 08, 2018	2018 (Q3)	―-0.49	-0.2	-150.00% (-0.29)
Aug 09, 2018	2018 (Q2)	―-3.13	-0.43	-619.54% (-2.69)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Dianthus Therapeutics earnings date